Karuna Therapeutics, Inc. (KRTX) — Analyst outlook / Analyst consensus target is. Based on 25 analyst ratings, the consensus is bullish — 16 Buy, 9 Hold.
The consensus price target is $257.50 (low: $150.00, high: $330.00), representing a downside of 21.9% from the current price $329.83.
KRTX Stock — 12-Month Price Forecast
$257.50
▼ -21.93% Downside
Average Price Target
Based on 25 Wall Street analysts offering 12-month price targets for Karuna Therapeutics, Inc., the average price target is $257.50, with a high forecast of $330.00, and a low forecast of $150.00.
The average price target represents a -21.93% change from the last price of $329.83.
Highest Price Target
$330.00
Average Price Target
$257.50
Lowest Price Target
$150.00
KRTX Analyst Ratings
Buy
Based on 25 analysts giving stock ratings to Karuna Therapeutics, Inc. in the past 3 months
